Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Microstent favoured in France

This article was originally published in Clinica

Executive Summary

The AVE Microstent has captured around 26% of the UK market and a significant share of the European market. Dr Bernard Vales' group, from the UCV in Marseille and ICV Paris Sud, France, now use the AVE stent in 90% of stenting procedures. He explained that the multi-length family of stents is much more adaptable to different lesions than other designs. In fact his praise was so glowing that one American member of the audience was led to ask why the Europeans used any other stent. The Palmaz-Schatz stent is used by Dr Vales' group in 5.6%.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087714

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel